Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis

NCT00041756 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: PG-530742
DRUG: Placebo
DRUG: 50 mg PG-530742
DRUG: 100 mg PG-530742
DRUG: 200 mg PG-530742

Sponsor

Procter and Gamble